MENU
TBXU
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

TBXU stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index... Show more

Category: #Trading
TBXU
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for TBXU with price predictions
Sep 25, 2026

TBXU in +5.41% Uptrend, advancing for three consecutive days on September 22, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TBXU advanced for three days, in 38 of 42 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 24, 2026. You may want to consider a long position or call options on TBXU as a result. In 11 of 13 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

TBXU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 27 of 34 cases where TBXU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Bearish Trend Analysis

The 10-day RSI Indicator for TBXU moved out of overbought territory on September 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 10 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 11 of 15 cases where TBXU's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for TBXU turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 5 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TBXU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the index, and exchange-traded funds ("ETFs") that track the index, that, in combination, provide 2X daily leveraged exposure to the index, consistent with the fund's investment objective. The components of the index and the percentages represented by various sectors in the index may change over time. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF is 135.78B. The market cap for tickers in the group ranges from 59.44B to 219.52B. AMGN holds the highest valuation in this group at 219.52B. The lowest valued company is ARGX at 59.44B.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF was 4%. For the same ETF, the average monthly price growth was -10%, and the average quarterly price growth was 31%. AMGN experienced the highest price growth at 8%, while ARGX experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF was -72%. For the same stocks of the ETF, the average monthly volume growth was -0% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 37
P/E Growth Rating: 36
Price Growth Rating: 43
SMR Rating: 50
Profit Risk Rating: 27
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
TBXU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
TBXU in +5.41% Uptrend, advancing for three consecutive days on September 22, 2026